The Worldwide Protein Labeling Industry is Expected to Reach $3.2 Billion by 2028

DUBLIN, Aug. 18, 2022 /PRNewswire/ -- The "Global Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application, By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

The Global Protein Labeling Market size is expected to reach $3.2 billion by 2028, rising at a market growth of 7.5% CAGR during the forecast period.

Proteins are the biggest macro molecules in a living creature, as they are essential for its survival. In addition, proteins engage with other bio molecules and carry out duties to keep the cell alive once they are created within a cell. As a result, proteomics and protein chemistry is being used to investigate the protein binding mechanism.

The majority of these techniques revolve around the ability to create genetic fusions that selectively target proteins, resulting in unique features for selective protein imaging, manipulation, and trapping within complex biochemical settings. To conduct successful protein labeling, a variety of procedures are used.

There is an employment of a variety of methods to label proteins, including the use of specific enzymes or probes. Alkaline phosphatase (AP) and horseradish peroxidase are two often utilized enzyme-protein conjugates (HRP). Enzyme-protein labeling systems have a number of advantages, including signal amplification, a variety of signal outputs, and a wide range of substrates for each enzyme.

Fluorescent, chemiluminescent, and colorimetric detection are common signal outputs. These signal outputs are suited for immunohistochemistry (IHC) or immunofluorescent (IF)-based detection applications in cells and tissues because of the wide range of signal outputs.

For examining the function and distribution of proteins in living and fixed cells, the SNAP-tag, CLIP-tag, and ACP-tag/MCP-tag protein labeling technologies provide a new alternative to standard fluorescent proteins. Covalent protein labeling makes imaging mammalian proteins in living cells easier and more versatile, as well as allowing for protein capture in vitro. A fusion protein is created by covalently attaching a single genetic construct to a range of substrates, such as fluorophores, biotin, and beads, to provide a potent tool for investigating proteins.

COVID-19 Impact Analysis

COVID-19 has quickly expanded in terms of confirmed cases and reported deaths, many countries are among the worst impacted by this pandemic. Owing to lockdowns, travel bans, and business shutdowns, the COVID-19 has had a negative impact on economies and businesses in a number of countries. The closure of various plants and factories has had a severe influence on comprehensive supply chains, negatively affecting manufacturing, delivery schedules, and product sales in the market. A few companies have already stated that there may be delays in product deliveries and a drop in future sales. Moreover, travel prohibitions implemented by countries are harming prospects for commercial cooperation and partnerships.

Market Growth Factors

Increasing healthcare expenditure to create more health prospects

Healthcare spending can lead to greater health opportunities, which can help to enhance human capital and increase productivity, boosting economic performance. As a result, assessing the phenomena of healthcare spending in a country is critical. Overall, the findings point to a robust link between healthcare spending and economic variables such as income, GDP, and labor productivity.

Healthcare spending is positively related to labor productivity, personal spending, and GDP indicators. With more spending by regional governments and healthcare bodies on the enhancement of medical technologies like protein labeling, the method of attaching fluorescent dyes to functional groups in biomolecules such that fluorescence imaging can easily be used to see them.

Rising R&D spending on healthcare industry

The ability of health research to contribute to the formation of advanced medical technology like protein labeling accounts for its significant effect. The medical association of various now spends significantly more on research and development (R&D) than other countries, which has been proved to contribute to innovation and the eventual development of a knowledge-based economy. Improving R&D investment is one of those investments that reap a huge reward for the comprehensive industry as it innovates and establishes a knowledge-based economy.

Market Restraining Factors

Shortage of skilled and competent professionals

In some region, there is a huge scarcity of skilled professionals, which is hindering the recovery & progress. Along with that, there is a severe issue of unemployment and a lack of chances stymie social cohesion and enhancement. Unemployed or underemployed people may have abilities that are in short supply everywhere.

Companies have identified the top three effects of skills shortages as being compelled to hire ill-suited personnel, lost production opportunities, and decreased company investment and product development - all of which hamper companies' ability to compete. Productivity might suffer as a result of a shortage of qualified workers, resulting in longer production times, higher operating costs, and other concerns.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Protein Labeling Market

Chapter 4. Global Protein Labeling Market by Method
4.1 Global In-vitro Market by Region
4.2 Global Protein Labeling Market by In-vitro Type
4.2.1 Global Enzymatic Market by Region
4.2.2 Global Dye-based Market by Region
4.2.3 Global Co-translational Market by Region
4.2.4 Global Site-specific Market by Region
4.2.5 Global Nanoparticle Market by Region
4.2.6 Global Others Market by Region
4.3 Global In-vivo Market by Region
4.4 Global Protein Labeling Market by In-vivo Type
4.4.1 Global Photoreactive Market by Region
4.4.2 Global Radioactive Market by Region
4.4.3 Global Others Market by Region

Chapter 5. Global Protein Labeling Market by Product
5.1 Global Reagents Market by Region
5.2 Global Kits Market by Region
5.3 Global Services Market by Region

Chapter 6. Global Protein Labeling Market by Application
6.1 Global Immunological Techniques Market by Region
6.2 Global Cell-based Assays Market by Region
6.3 Global Fluorescence Microscopy Market by Region
6.4 Global Protein Microarray Market by Region
6.5 Global Mass Spectrometry Market by Region

Chapter 7. Global Protein Labeling Market by Region

Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments
8.1.5.1 Acquisition and Mergers
8.1.6 SWOT Analysis
8.2 Merck Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 PerkinElmer, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments
8.3.5.1 Product Launches and Product Expansions
8.3.5.2 Acquisition and Mergers
8.4 General Electric (GE) Co.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Kaneka Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 New England BioLabs, Inc.
8.7.1 Company Overview
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments
8.8.2.1 Partnerships, Collaborations, and Agreements
8.9 LI-COR, Inc.
8.9.1 Company Overview
8.10. SeraCare Life Sciences (LGC Standards Ltd.)
8.10.1 Company Overview

For more information about this report visit https://www.researchandmarkets.com/r/hdbefe

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets